Cargando…
Comparative Evaluation of Direct Thrombin and Factor Xa Inhibitors with Antiplatelet Agents under Flow and Static Conditions: An In Vitro Flow Chamber Model
Dabigatran and rivaroxaban are novel oral anticoagulants that specifically inhibit thrombin and factor Xa, respectively. The aim of this study is to elucidate antithrombotic properties of these anticoagulant agents under arterial and venous shear conditions. Whole blood samples treated with dabigatr...
Autores principales: | Hosokawa, Kazuya, Ohnishi, Tomoko, Sameshima, Hisayo, Miura, Naoki, Koide, Takehiko, Maruyama, Ikuro, Tanaka, Kenichi A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908954/ https://www.ncbi.nlm.nih.gov/pubmed/24497951 http://dx.doi.org/10.1371/journal.pone.0086491 |
Ejemplares similares
-
A modified microchip-based flow chamber system for evaluating thrombogenicity in patients with thrombocytopenia
por: Atari, Bengo, et al.
Publicado: (2020) -
The Tick-Derived Anticoagulant Madanin Is Processed by Thrombin and Factor Xa
por: Figueiredo, Ana C., et al.
Publicado: (2013) -
Thrombin and factor Xa link the coagulation system with liver fibrosis
por: Dhar, Ameet, et al.
Publicado: (2018) -
Thrombin Receptor Antagonism in Antiplatelet Therapy
por: Olivier, C., et al.
Publicado: (2013) -
Procoagulant activity of human tumours: existence of Xa and thrombin-like activities.
por: Sarode, R., et al.
Publicado: (1990)